approval
saveNURTEC ODT (RIMEGEPANT SULFATE) — FDA approval
community read0 votes
Sponsor: PFIZER. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalMar 16, 2026 · 203d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalAug 1, 2025 · 430d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalMar 21, 2025 · 563d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalDec 12, 2024 · 662d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalApr 11, 2022 · 1638d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalMar 31, 2022 · 1649d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalDec 8, 2021 · 1762d ago
- approvalNURTEC ODT (RIMEGEPANT SULFATE) — FDA approvalMay 27, 2021 · 1957d ago
same company · ±60 days · 4
- approvalCLEOCIN: CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approvalMar 4, 2020
- approvalCLEOCIN: CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approvalMar 4, 2020
- approvalclindamycin hydrochloride: CLEOCIN HYDROCHLORIDE (CLINDAMYCIN HYDROCHLORIDE) — FDA approvalMar 9, 2020
- approvalIXIFI: IXIFI (INFLIXIMAB-QBTX) — FDA approvalJan 16, 2020
comments(0)
5-min edit window · permanent after that